K. Bader

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer

M. Rettenmaier, John V. Brown, M. Genesen, 2006, International Journal of Gynecologic Cancer.

Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer.

J. Mattison, M. Markman, M. Rettenmaier, 2005, Gynecologic oncology.